Clinical Trial Update: Evaluation of the Pharmacodynamic Effect of the Combination of Sildenafil and Riociguat on Blood Pressure and Other Safety Parameters. [Phase 2]

View source ↗

Summary

Phase 2 study examined the pharmacodynamic effects and safety parameters of combining sildenafil with riociguat in pulmonary hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Riociguat (riociguat)
• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Bayer | Conditions: Pulmonary Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2013-12-25